BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaquero L, Bernardo D, León F, Rodríguez-martín L, Alvarez-cuenllas B, Vivas S. Challenges to drug discovery for celiac disease and approaches to overcome them. Expert Opinion on Drug Discovery 2019;14:957-68. [DOI: 10.1080/17460441.2019.1642321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Gala D, Scharf S, Kudlak M, Green C, Khowaja F, Shah M, Kumar V, Ullal G. A Comprehensive Review of the Neurological Manifestations of Celiac Disease and Its Treatment. Diseases 2022;10. [PMID: 36412605 DOI: 10.3390/diseases10040111] [Reference Citation Analysis]
2 Sharma K, Bhawanani S, Sharma D, Goel G. Selection of indigenous Lacticaseibacillus paracasei CD 4 for production of gluten-free traditional fermented product Bhaturu. Food Biotechnology 2022;36:76-91. [DOI: 10.1080/08905436.2021.2007395] [Reference Citation Analysis]
3 Enomoto H, Yeatts J, Carbajal L, Krishnan BR, Madan JP, Laumas S, Blikslager AT, Messenger KM. In vivo assessment of a delayed release formulation of larazotide acetate indicated for celiac disease using a porcine model. PLoS One 2021;16:e0249179. [PMID: 33844694 DOI: 10.1371/journal.pone.0249179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Arranz E, De Prado Á, Fiz-López A, Arribas E, Garrote JA, Bernardo D. Human intestinal dendritic cell and macrophage subsets in coeliac disease. Int Rev Cell Mol Biol 2021;358:85-104. [PMID: 33707058 DOI: 10.1016/bs.ircmb.2020.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]